Pacritinib and Chemotherapy in Treating Patients With Acute Myeloid Leukemia and FLT3 Mutations

Clinical trial NCT02323607 · COMPLETED

Trial details

NCT number: NCT02323607
Sponsor: Bhavana Bhatnagar
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Recurrent Adult Acute Myeloid Leukemia Secondary Acute Myeloid Leukemia Therapy-Related Acute Myeloid Leukemia Untreated Adult Acute Myeloid Leukemia

Start date: 2016-01-12
Primary completion: 2018-07-12
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.